Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Bull: UiPath successfully monetizes its AI agentic platform, re-accelerating top-line growth to double digits and reaching a 30%+ operating margin, fully justifying a $13.97 fair value.
AI Generative Disruption: Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.
UiPath is a market leader in Robotic Process Automation (RPA) transitioning into a broader AI and process orchestration platform. While top-line growth has decelerated from its hyper-growth phase to high single digits, the company has recently turned profitable, demonstrating the operating leverage inherent in its 83% gross margin profile.
UiPath is a market leader in Robotic Process Automation (RPA) transitioning into a broader AI and process orchestration platform. While top-line growth has decelerated from its hyper-growth phase to high single digits, the company has recently turned profitable, demonstrating the operating leverage inherent in its 83% gross margin profile.
High switching costs embedded deep within enterprise legacy workflows.
Incumbent scale and broad integrations in traditional RPA markets.
Enterprise AI adoption drives massive structural process orchestration needs across sectors.
Hold. Current valuation fully captures the transition to mature unit economics but lacks a sufficient margin of safety against significant execution and competitive risks.
UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent builder; RPA and API automation; UiPath intelligent xtraction and processing; UiPath test cloud for testing and quality assurance; UiPath packaged and prebuilt agentic solutions; and centralized governance capabilities that apply across automations, AI agents, and manual tasks. It serves the financial services, healthcare, manufacturing, retail, and public sectors. The company was founded in 2005 and is headquartered in New York, New York.
A recessionary enterprise software budget freeze coupled with Microsoft bundling forces drastic pricing cuts. Base case growth of 9% plummets to 0%, while fixed R&D and SBC costs severely destroy GAAP margins.
High switching costs embedded deep within enterprise legacy workflows.
Incumbent scale and broad integrations in traditional RPA markets.
Economic profit is supported when reported returns exceed the company cost-of-capital hurdle.
Unavailable
FCFF DCF remains positive at the base case: base FCFF $37.7M after capex $24.2M, with terminal value at 53.3% of enterprise value. No FCF cliff is projected unless capex/ or materially resets.
If forward revenue growth structurally exceeds 9% and operating margins expand, the market will rapidly rotate valuation toward the $13.97 bull case.
If forward revenue growth structurally exceeds 9% and operating margins expand, the market will rapidly rotate valuation toward the $13.97 bull case.
Maturing software phase strictly prioritizing FCF conversion and capital return over growth at all costs.
Enterprise AI adoption drives massive structural process orchestration needs across sectors.
Broad IT budget consolidation heavily favors mega-cap incumbents with bundled solutions.
Maturing software phase strictly prioritizing FCF conversion and capital return over growth at all costs.
Hold existing positions. There is currently no margin of safety to initiate new buys at current valuation levels.
Trim exposure aggressively if shares approach the $13.97 bull case without a structural re-acceleration in top-line growth.
Maintain a Hold rating. The $10.98 composite fair value represents highly accurate pricing of the company's mature compounding trajectory weighed against ongoing execution risks.
While the transition to positive free cash flow is highly commendable, the persistent ~18% SBC burden and intense competitive environment heavily cap the upside potential.
Maintain a Hold rating. The $10.98 composite fair value represents highly accurate pricing of the company's mature compounding trajectory weighed against ongoing execution risks.
Reassess the thesis against the named valuation, risk, and quarterly checkpoint evidence in this report.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Microsoft and other hyperscalers aggressively commoditize traditional RPA, stalling UiPath's growth and forcing severe margin compression, dragging fair value down to $8.05.
Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.
Intense competitive pricing pressure from Microsoft prevents operating margins from reaching the 25% terminal assumption.
Inability to retain engineering talent forces higher stock-based compensation, permanently impairing free cash flow to equity.
The five developments that would weaken our investment case.
Decelerating revenue growth signals enterprise automation budget fatigue and competitive displacement by generative AI agents, threatening recurring cash flow streams and undermining premium valuation multiples.
Current:12.7% for the period ended 2026-01-31
Alert if< 8.0% over two consecutive fiscal quarters
A breakdown in cash flow conversion indicates that high equity compensation and working capital drag are eroding earnings quality, limiting the self-funded cash generation necessary to repurchase shares and offset dilution.
Current:1.315 as of 2026-05-10
Alert if< 1.000 over two consecutive fiscal quarters
Sustained gross margin degradation reveals severe pricing pressure from bundled cloud orchestrators, eroding the high software gross profit needed to sustain sales distribution and platform development.
Current:83.2% for the period ended 2026-01-31
Alert if< 80.0% over any trailing twelve-month period
Failing to expand operating margins toward steady-state targets proves that organizational overhead is inflexible against competitive pricing, breaking the operating leverage model essential for institutional valuation support.
Current:3.5% for the period ended 2026-01-31
Alert if< 0.0% over two consecutive fiscal quarters
Negative returns on invested capital indicate that generative AI agent substitutes are commoditizing standalone robotic automation workflows, destroying economic value and nullifying the platform's competitive advantage.
Current:2.1% as of 2026-05-10
Alert if< 0.0% over two consecutive fiscal quarters
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Project SBC-adjusted EPS, discount each year's earnings at cost of equity, then add a Gordon-growth terminal value.
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and at , then adjust for signed per current share.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Multiply the peer median PEG by this stock's forecast growth to derive an implied forward P/E, then apply it to forward EPS.
Solve for the growth rate that makes the model value equal the report-date share price.
UiPath successfully monetizes its AI agentic platform, re-accelerating top-line growth to double digits and reaching a 30%+ operating margin, fully justifying a $13.97 fair value.
The company transitions smoothly to a mature compounder, stabilizing revenue growth at 6-9% while achieving a 25% normalized operating margin over the forecast period.
If forward revenue growth structurally exceeds 9% and operating margins expand, the market will rapidly rotate valuation toward the $13.97 bull case.
If forward revenue growth structurally exceeds 9% and operating margins expand, the market will rapidly rotate valuation toward the $13.97 bull case.
Warning level: < 8.0% over two consecutive fiscal quarters. Decelerating revenue growth signals enterprise automation budget fatigue and competitive displacement by generative AI agents, threatening recurring cash flow streams and undermining premium valuation multiples.
Warning level: < 1.000 over two consecutive fiscal quarters. A breakdown in cash flow conversion indicates that high equity compensation and working capital drag are eroding earnings quality, limiting the self-funded cash generation necessary to repurchase shares and offset dilution.
Warning level: < 80.0% over any trailing twelve-month period. Sustained gross margin degradation reveals severe pricing pressure from bundled cloud orchestrators, eroding the high software gross profit needed to sustain sales distribution and platform development.
Warning level: < 0.0% over two consecutive fiscal quarters. Failing to expand operating margins toward steady-state targets proves that organizational overhead is inflexible against competitive pricing, breaking the operating leverage model essential for institutional valuation support.
Warning level: < 0.0% over two consecutive fiscal quarters. Negative returns on invested capital indicate that generative AI agent substitutes are commoditizing standalone robotic automation workflows, destroying economic value and nullifying the platform's competitive advantage.
| — |
| $1.06B |
| $1.31B |
| $1.43B |
| $1.61B |
| +15.0% |
| Gross profit | — | $878.5M | $1.11B | $1.18B | $1.34B | +15.1% |
| Operating income | — | $-348.3M | $-164.7M | $-162.6M | $56.8M | — |
| Net income | — | $-328.4M | $-89.9M | $-73.7M | $282.3M | — |
| EPS (diluted) | $-1.16 | $-0.60 | $-0.16 | $-0.13 | — | — |
| EBITDA | — | $-329.6M | $-142.1M | $-145.3M | $73.7M | — |
| R&D | — | $285.8M | $332.1M | $380.7M | $385.2M | +10.5% |
| SG&A | — | $941.1M | $944.8M | $964.6M | $897.6M | -1.6% |
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Revenue | 1,610,572,000 |
|---|---|
| Cost of revenue | 270,984,000 |
| Gross profit | 1,339,588,000 |
| Operating expenses | 1,282,828,000 |
| Operating income | 56,760,000 |
| Non-operating items and tax | 225,570,000 |
| Net income | 282,330,000 |
| Total assets | 3,179,200,000 |
|---|---|
| Cash | 871,157,000 |
| Current assets | 2,243,945,000 |
| Total liabilities | 1,096,613,000 |
| Current liabilities | 905,423,000 |
| Shareholders’ equity | 2,082,587,000 |
Point-in-time financial data used in the 2026-05-10 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-31 | — | — | — | — | — | — | — | — | — | — | 0 | — | — | — | — | — | — | — | — | — | — |
| 2023-01-31 | 1.1B | -329.6M | -328.4M | -10M | -33.8M | 23.8M | 18.7M | 369.8M | 0 | — | 0 | — | — | — | — | 1.4B | 63.4M | -32.9% | — | — | — |
| 2024-01-31 | 1.3B | -142.1M | -89.9M | 299.1M | 291.7M | 7.3M | 22.6M | 372M | 102.6M | — | — | — | — | — | — | 1.1B | 67.1M | -12.6% | — | 11.2% | — |
| 2025-01-31 | 1.4B | -145.3M | -73.7M | 320.6M | 305.6M | 14.9M | 17.2M | 358.2M | 390.8M | — | — | — | — | — | — | 879.2M | 77.8M | -11.4% | — | 11.3% | — |
| 2026-01-31 | 1.6B | 73.7M | 282.3M | 371.2M | 352.2M | 19M | 17M | 290.7M | 329.1M | — | — | — | — | — | — | 871.2M | 81.2M | 3.5% | — | 10.9% | — |
PATH trades at 12.0x forward earnings against a peer median of 52.4x; EV/EBITDA of 56.4x against a peer median of 107.7x; 5 peers.
| Oracle Corporation |
| 24.4x |
| 8.8x |
| 25.2x |
| 57.6% |
| 32.7% |
| PLTR | Palantir Technologies Inc. | 66.9x | 63.2x | 159.9x | 32.6% | 46.2% |
| PANW | Palo Alto Networks Inc. | 52.4x | 17.0x | 107.7x | 16.3% | 15.5% |
